CLINICAL_TRIALS
trial_result
· 2012-07-10
Clinical Trial Update: HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis [Phase 3]
Summary
Phase 3 trial update evaluating adalimumab (Humira) to spare steroid use in giant cell arteritis; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Giant Cell Arteritis | Phase 3 | Status: COMPLETED